Treasury Chief Rachel Reeves Intends Focused Measures on Household Expenses in Forthcoming Budget
Chancellor Reeves has stated she is preparing "specific measures to address cost of living issues" in the upcoming financial statement.
In comments to the BBC, she emphasized that reducing price rises is a joint duty of both the administration and the central bank.
The United Kingdom's price growth is forecast to be the highest among the G7 developed nations this year and next.
Possible Utility Cost Measures
Reports indicate the government could intervene to lower utility costs, for instance by cutting the present 5% level of value-added tax applied on energy supplies.
Another possibility is to reduce some of the regulatory levies presently added to bills.
Budgetary Limitations and Expert Predictions
The administration will receive the next draft from the official forecaster, the OBR, on the start of the week, which will reveal how much scope there is for such measures.
The consensus from the majority of analysts is that Reeves will have to declare tax increases or spending cuts in order to adhere to her voluntary debt limits.
Previously on the same day, analysis suggested there was a £22bn gap for the chancellor to resolve, which is at the lower end of projections.
"It is a collective responsibility between the central bank and the administration to continue tackling some of the sources of price increases," the Chancellor told reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.
Revenue Pledges and International Concerns
While much of the focus has been on expected tax rises, the Treasury chief said the most recent figures from the fiscal watchdog had not changed her commitment to manifesto promises not to raise rates on earnings tax, sales tax or social security contributions.
She blamed an "uncertain global environment" with increasing international and trade issues for the Budget tax moves, probably to be directed on those "most able to pay."
Global Economic Tensions
Addressing apprehensions about the UK's commercial links with the Asian nation she said: "Our security interests invariably are paramount."
Last week's declaration by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are key for advanced tech production led US President the US President to suggest an further 100% import tax on goods from the Asian country, raising the risk of an all-out trade war between the two global powers.
The US Treasury Secretary described the Chinese decision "economic coercion" and "a global supply chain power grab."
Asked about accepting the US offer to participate in its battle with China, Reeves said she was "extremely troubled" by China's measures and encouraged the Beijing authorities "not to put up barriers and restrict access."
She said the decision was "harmful for the world economy and causes additional obstacles."
"It is my opinion there are areas where we need to confront Chinese policies, but there are also valuable prospects to export to Chinese markets, including banking sector and other areas of the economy. We've got to maintain that equilibrium appropriate."
The chancellor also stated she was cooperating with G7 counterparts "on our own critical minerals strategy, so that we are reduced dependence."
Health Service Medicine Pricing and Funding
The Chancellor also recognized that the cost the National Health Service pays for medicines could increase as a consequence of ongoing discussions with the Trump administration and its drugs companies, in return for lower tariffs and funding.
A number of the world's largest pharmaceutical manufacturers have said lately that they are either delaying or canceling investments in the UK, with several attributing the insufficient payments they are obtaining.
Last month, the Science Minister said the price the NHS spends on medicines would have to rise to halt businesses and pharmaceutical investment leaving the UK.
Reeves told the BBC: "It has been observed due to the payment system, that medical research, innovative medicines have not been provided in the United Kingdom in the manner that they are in other European countries."
"Our aim is to ensure that patients receiving treatment from the National Health Service are able to access the best life-saving treatments in the globe. And so we are reviewing these issues, and... looking to attract more investment into Britain."